These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36301355)

  • 1. Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysis.
    Karolyi M; Kaltenegger L; Pawelka E; Kuran A; Platzer M; Totschnig D; Koenig F; Hoepler W; Laferl H; Omid S; Seitz T; Traugott M; Arthofer S; Erlbeck L; Jaeger S; Kettenbach A; Assinger A; Wenisch C; Zoufaly A
    Wien Klin Wochenschr; 2022 Dec; 134(23-24):883-891. PubMed ID: 36301355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with moderate to severe COVID-19 outcomes on remdesivir according to baseline 4C mortality score.
    Sellers J; Chang J; Jones J; Hintze TD
    Pulm Pharmacol Ther; 2023 Feb; 78():102188. PubMed ID: 36603741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir versus Favipiravir in Hospitalized Patients with Moderate to Severe COVID-19 Pneumonia: A Propensity Score-Matched Retrospective Cohort Study.
    Chavalertsakul K; Sutherasan Y; Petnak T; Thammavaranucupt K; Kirdlarp S; Boonsarngsuk V; Sungkanuparph S
    Int J Gen Med; 2024; 17():2163-2175. PubMed ID: 38770366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
    Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y
    JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.
    Veronese N; Di Gennaro F; Frallonardo L; Ciriminna S; Papagni R; Carruba L; Agnello D; De Iaco G; De Gennaro N; Di Franco G; Naro L; Brindicci G; Rizzo A; Bavaro DF; Garlisi MC; Santoro CR; Signorile F; Balena F; Mansueto P; Milano E; Giannitrapani L; Fiordelisi D; Mariani MF; Procopio A; Lattanzio R; Licata A; Vernuccio L; Amodeo S; Guido G; Segala FV; Barbagallo M; Saracino A
    Sci Rep; 2024 Apr; 14(1):9303. PubMed ID: 38654033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Improvement, Outcomes, Antiviral Activity, and Costs Associated With Early Treatment With Remdesivir for Patients With Coronavirus Disease 2019 (COVID-19).
    Wong CKH; Lau KTK; Au ICH; Xiong X; Lau EHY; Cowling BJ
    Clin Infect Dis; 2022 Apr; 74(8):1450-1458. PubMed ID: 34265054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
    Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
    PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Read SH; Lee E; Der-Torossian C; Gupta R; Berry M; Hollemeersch S; Kalil AC
    Open Forum Infect Dis; 2023 Oct; 10(10):ofad482. PubMed ID: 37869410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir Reduced Mortality in Immunocompromised Patients Hospitalized for COVID-19 Across Variant Waves: Findings From Routine Clinical Practice.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Read SH; Jiang H; Chiang M; Lee E; Gupta R; Berry M; Kalil AC
    Clin Infect Dis; 2023 Dec; 77(12):1626-1634. PubMed ID: 37556727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen.
    Mozaffari E; Chandak A; Chima-Melton C; Kalil AC; Jiang H; Lee E; Der-Torossian C; Thrun M; Berry M; Haubrich R; Gottlieb RL
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae202. PubMed ID: 38894848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
    Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
    J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Multidimensional Prognostic Index to Identify Hospitalized Older Adults with COVID-19 Who Can Benefit from Remdesivir Treatment: An Observational, Prospective, Multicenter Study.
    Custodero C; Veronese N; Topinkova E; Michalkova H; Polidori MC; Cella A; Cruz-Jentoft AJ; von Arnim CAF; Azzini M; Gruner H; Castagna A; Cenderello G; Custureri R; Zieschang T; Padovani A; Sanchez-Garcia E; Pilotto A;
    Drugs Aging; 2023 Jul; 40(7):643-651. PubMed ID: 37310575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study.
    Mengato D; Mazzitelli M; Francavilla A; Bettio M; Sasset L; Presa N; Pivato L; Lo Menzo S; Trevenzoli M; Venturini F; Gregori D; Cattelan AM
    Clin Exp Med; 2023 Oct; 23(6):2749-2756. PubMed ID: 36961678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: A propensity score adjusted retrospective cohort study.
    Koh LP; Chua SL; Vasoo S; Toh MPHS; Cutter JN; Nah PH; Leo YS; Tay JX; Young BE; Lye DC; Ong SWX
    J Med Virol; 2023 Feb; 95(2):e28460. PubMed ID: 36602046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Propensity Score-Matched Observational Study of Remdesivir in Patients with COVID-19 and Severe Kidney Disease.
    Seethapathy R; Zhao S; Long JD; Strohbehn IA; Sise ME
    Kidney360; 2022 Feb; 3(2):269-278. PubMed ID: 35373125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study.
    Rajme-López S; Martinez-Guerra BA; Román-Montes CM; Tamez-Torres KM; Tello-Mercado AC; Tepo-Ponce KM; Segura-Ortíz Z; López-Aguirre A; Gutiérrez-Mazariegos ODR; Lazcano-Delgadillo O; Nares-López R; González-Lara MF; Kershenobich-Stalnikowitz D; Sifuentes-Osornio J; Ponce-de-León A; Ruíz-Palacios GM
    Ther Adv Infect Dis; 2024; 11():20499361241236582. PubMed ID: 38545451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience.
    Attena E; Caturano A; Annunziata A; Maraolo AE; De Rosa A; Fusco FM; Halasz G; Dall'Ospedale V; Conte M; Parisi V; Galiero R; Sasso FC; Fiorentino G; Russo V
    Eur J Clin Pharmacol; 2023 Jul; 79(7):967-974. PubMed ID: 37212843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.
    Chokkalingam AP; Hayden J; Goldman JD; Li H; Asubonteng J; Mozaffari E; Bush C; Wang JR; Kong A; Osinusi AO; Gottlieb RL
    JAMA Netw Open; 2022 Dec; 5(12):e2244505. PubMed ID: 36454570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of remdesivir on SARS-CoV-2 viral dynamics and mortality in viraemic patients hospitalized for COVID-19.
    Hagman K; Hedenstierna M; Widaeus J; Arvidsson E; Hammas B; Grillner L; Jakobsson J; Gille-Johnson P; Ursing J
    J Antimicrob Chemother; 2023 Nov; 78(11):2735-2742. PubMed ID: 37757451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.